PATHMAKER NEUROSYSTEMS
PathMaker Neurosystems is a neurotechnology company that develops treatment for neuromotor disorders.
PATHMAKER NEUROSYSTEMS
Industry:
Biotechnology Health Care Life Science Medical
Founded:
1907-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.pmneuro.com
Total Employee:
1+
Status:
Active
Contact:
617-535-7650
Email Addresses:
[email protected]
Total Funding:
5.1 M USD
Technology used in webpage:
Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Nginx
Current Employees Featured
Founder
Investors List
MassVentures
MassVentures investment in Grant - PathMaker Neurosystems
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - PathMaker Neurosystems
Official Site Inspections
http://www.pmneuro.com
- Host name: tizinc.com
- IP address: 216.70.109.81
- Location: Culver City United States
- Latitude: 34.0141
- Longitude: -118.3983
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90232
More informations about "PathMaker Neurosystems"
Management Team โ PathMaker Neurosystems - pmneuro.com
Overview โ PathMaker Neurosystems - pmneuro.com
Overview. PathMaker Neurosystems is opening up a new era of non-invasive treatment of ALS and other serious neurological disorders.Our vision is to make ALS a livable disease through โฆSee details»
PathMaker Neurosystems - Crunchbase Company Profile & Funding
Organization. PathMaker Neurosystems . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; โฆSee details»
Muscular Dystrophy Association Awards Venture โฆ
For more information, please visit the company website at www.pmneuro.com. About Muscular Dystrophy Association. Muscular Dystrophy Association (MDA) is the #1 voluntary health organization in the United States for people living with โฆSee details»
Muscular Dystrophy Association Awards Venture Philanthropy โฆ
Jan 17, 2023 Muscular Dystrophy Association Awards Venture Philanthropy Funding to PathMaker Neurosystems to Develop Neuromodulation Treatment for ALSSee details»
PathMaker Neurosystems Announces Initiation of First-in-Human โฆ
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (โPathMakerโ), a near-commercial stage neuromodulation company developing breakthrough โฆSee details»
Contact Us โ PathMaker Neurosystems - pmneuro.com
New York, New York PathMaker Neurosystems Inc. 667 Madison Avenue, 4th Floor New York, NY 10065 617-535-7696 office 617-535-7650 fax [email protected]See details»
Muscular Dystrophy Association Awards Venture Philanthropy
Jan 17, 2023 Muscular Dystrophy Association (MDA) is the #1 voluntary health organization in the United States for people living with muscular dystrophy, ALS, and related neuromuscular โฆSee details»
PathMaker Neurosystems Receives $100,000 START Award from โฆ
BOSTON, June 08, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (โPathMakerโ), a near-commercial stage neuromodulation company developing breakthrough non-invasive โฆSee details»
PathMaker Neurosystems Announces Initiation of - GlobeNewswire
Sep 14, 2023 For more information, please visit the company website at www.pmneuro.com. Media contact: PathMaker PR (617) 535-7696 [email protected]. TagsSee details»
PathMaker Neurosystems Appoints Leading Neurotechnology โฆ
BOSTON and PARIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (โPathMakerโ), a near-commercial stage neuromodulation company developing breakthrough โฆSee details»
PathMaker Neurosystems Receives $200,000 START Award from
Jun 5, 2023 At PathMaker, we are opening up a new era of non-invasive therapy that promises to restore mobility and function in people with serious neurological disorders. For more โฆSee details»
PathMaker Neurosystems Announces $2.16 Million Award from โฆ
Jun 5, 2024 MyoRegulator® and MyoRegulator® ALS are investigational medical devices and are limited by Federal law to investigational use only. For more information, please visit the โฆSee details»
PathMaker Neurosystems Announces Receipt of NIH Grant For
BOSTON and PARIS, Sept. 20, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (โPathMakerโ), a near-commercial stage neuromodulation company...See details»
PathMaker Neurosystems Announces Completion of Pivotal โฆ
BOSTON and PARIS, Sept. 27, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (โPathMakerโ), a near-commercial stage neuromodulation company developing breakthrough โฆSee details»
Neuromodulation โ PathMaker Neurosystems - pmneuro.com
Neuromodulation. In the past two decades, there has been rapid acceleration in the development and use of neuromodulation technologies for the treatment of specific functional and โฆSee details»
Clinical Trials โ PathMaker Neurosystems - pmneuro.com
Clinical Trials Ongoing clinical trials CALM: Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study PathMaker Neurosystems is the sponsor of the CALM Study, an โฆSee details»
PathMaker Neurosystems Receives $200,000 START Award from
Jun 5, 2023 For more information, please visit the company website at www.pmneuro.com. Source: PathMaker Neurosystems Inc. Media contact: PathMaker PR (617) 535-7696 โฆSee details»
PathMaker Neurosystems Announces Completion of Pivotal
BOSTON and PARIS, Sept. 27, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (โPathMakerโ), a near-commercial stage neuromodulation company...See details»